Streetbeat News

Earnings

JRSH

Jerash Holdings reported a 21% increase in revenue and a 31% rise in gross profit for its fiscal 2025 second quarter, marking a return to profitability as global customers regain confidence.

Portfolio Pulse from

November 12, 2024 | 1:15 pm

NTIC

Northern Technologies International Corporation (NTIC) will release its fiscal 2024 fourth-quarter financial results on November 19, 2024, before the market opens. The results will be available on NTIC's Investor Relations webpage.

Portfolio Pulse from

November 12, 2024 | 1:15 pm

LYV

Live Nation Entertainment Inc's Ticketmaster reported a 17% revenue decline and a 33% drop in adjusted operating income in Q3, despite facing criticism over its dynamic pricing policies.

Portfolio Pulse from

November 12, 2024 | 1:15 pm

UAMY

United States Antimony Corporation (NYSE:UAMY) reported a 23% year-over-year increase in revenues for the first nine months of 2024, reaching $8.066 million. The cost of sales rose by 7%, while gross profit surged by 107%.

Portfolio Pulse from

November 12, 2024 | 1:15 pm

MVNC

Marvion Inc. (OTC: MVNC) reported a 150% year-over-year revenue growth for Q3 2024 and announced a new warehouse expansion. The company achieved $1,019,593 in revenue and $502,341 in gross profit for the first nine months of 2024.

Portfolio Pulse from

November 12, 2024 | 1:15 pm

HTZ

Hertz reported its third quarter 2024 results, emphasizing its transformation and back-to-basics strategy aimed at delivering sustainable, long-term returns for shareholders. CEO Gil West highlighted the team's commitment to customers and strategic objectives.

Portfolio Pulse from

November 12, 2024 | 1:15 pm

SMTK

Smartkem (Nasdaq: SMTK) reported its third quarter 2024 financial results, highlighting progress in commercializing its organic thin-film transistors (OTFTs) for next-generation displays.

Portfolio Pulse from

November 12, 2024 | 1:15 pm

NVAX

Novavax reported its Q3 2024 financial results, achieving $85 million in revenue and ending the quarter with $1 billion in cash and receivables. The U.S. FDA lifted the clinical hold on its COVID-19-Influenza combination and influenza vaccine candidates. Novavax received authorization for its updated COVID-19 vaccine for individuals aged 12 and older from both the U.S. FDA and the European Commission.

Portfolio Pulse from

November 12, 2024 | 1:15 pm

AVGO

Broadcom Inc. (NASDAQ: AVGO) will release its Q4 and fiscal year 2024 financial results on December 12, 2024, after market close.

Portfolio Pulse from

November 12, 2024 | 1:15 pm